Antidementia drug treatment in dementia networks in Germany: use rates and factors associated with treatment use

BACKGROUND: Dementia networks in Germany constitute a specialised setting for integrated dementia care and have shown benefits on relevant outcomes, including those of drug treatment. National guidelines recommend treatment with acetylcholinesterase inhibitors (donepezil, galantamine, rivastigmine)...

Descripción completa

Detalles Bibliográficos
Autores principales: Wübbeler, Markus, Wucherer, Diana, Hertel, Johannes, Michalowsky, Bernhard, Heinrich, Steffen, Meyer, Saskia, Schaefer-Walkmann, Susanne, Hoffmann, Wolfgang, Thyrian, Jochen René
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4460966/
https://www.ncbi.nlm.nih.gov/pubmed/25998147
http://dx.doi.org/10.1186/s12913-015-0855-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4460966/
https://www.ncbi.nlm.nih.gov/pubmed/25998147
http://dx.doi.org/10.1186/s12913-015-0855-7

Ejemplares similares